Followers | 523 |
Posts | 6631 |
Boards Moderated | 1 |
Alias Born | 07/24/2012 |
Sunday, October 07, 2012 11:51:20 PM
Amarantus BioSciences Announces Close of $10M
Equity Funding Facility with Centurion Private
Equity, LLC
SUNNYVALE, CA - October 13, 2011 – Amarantus Biosciences, Inc. (OTCBB: AMBS) a
biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic
protein that addresses an underlying form of cell death known as apoptosis, announced
today that it has closed a $10M Equity Funding Facility with Centurion Private Equity, LLC
(“Centurion”). The Company will have the ability to draw down on this facility over the course
of the next 36 months in tranches of up $750,000
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM